A corporate practice that, for much of the postwar period, was illegal under American securities regulation has, in the last four decades, become one of the standard uses to which large companies put their cash. A 'share buyback,' in which the company purchases its own stock from the public market, has overtaken dividends as the principal means by which profits are returned to shareholders. The economic logic, when first defended in the 1980s, was straightforward: a company that has more cash than it has investment opportunities should return the surplus to its owners, who can deploy it elsewhere. The defenders of the practice have continued to make this argument, with minor variations, for forty years.
The critics of the practice now form a substantial chorus of their own. Their charge, broadly stated, is that buybacks have less to do with returning surplus cash than with managing reported earnings per share, supporting the stock price during periods of slow growth, and aligning incentives for executives whose compensation depends on share-price performance. The defensible-sounding version of the practice — return cash you cannot otherwise use — coexists, on this view, with a less defensible practice in which companies borrow to buy back stock, redirecting capital that might have been invested in research or wages toward the elevation of a single number on the executive compensation contract.
Both characterisations contain truth, and the proportion in which they describe actual buyback activity has been the subject of an empirical literature whose findings shift, decade by decade, with the period studied. What the most careful work suggests is that buybacks vary across companies and across business cycles in ways that defy a single judgement: some buybacks are the textbook return of surplus, others are the executive-compensation manoeuvre the critics describe, and a substantial share are something in between. To treat the practice as inherently virtuous or inherently corrupt is to flatten a heterogeneous reality into the shape that suits the polemic at hand.
The honest position, then, is that buybacks are neither the simple efficiency the defenders claim nor the simple abuse the critics charge. A regulatory regime that distinguishes among kinds of buybacks — by the source of the cash, by the timing relative to executive compensation events, by the existence of foregone investment — is more useful than one that either bans the practice or treats it as automatically benign. The debate would be sharper if both sides spent less time on the practice in general and more time on the specific transactions whose features are actually in dispute.
The author's attitude toward the practice of share buybacks is best described as: